NEW YORK, April 21, 2016 /PRNewswire/ -- Harwood Feffer LLP
(www.hfesq.com) is investigating potential claims against the board
of directors of Hansen Medical, Inc. ("Hansen" or the "Company")
(NASDAQ: HNSN) concerning the proposed acquisition of the Company
by Auris Surgical Robotics, Inc. ("Auris").
Under the terms of the offer, the Auris would acquire Lexmark in
a transaction valued at approximately $80
million. Pursuant to the deal, Hansen stockholders
will receive $4 in cash per
share. Hansen stock traded above the offer price as recently
as September 2015.
Our investigation concerns whether the Hansen board of directors
is fulfilling its fiduciary duties, maximizing the value of the
Company, disclosing all material benefits and costs, and obtaining
full and fair consideration for Company stockholders.
If you own Hansen shares and wish to discuss this matter with
us, or have any questions concerning your rights and interests with
regard to this matter, please contact:
Benjamin I. Sachs-Michaels,
Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been
representing individual and institutional investors for many years,
serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website
(http://www.hfesq.com) for more information about the firm.
Attorney Advertising. The law firm responsible for this
advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results
do not guarantee or predict a similar outcome with respect to any
future matter.
Logo -
http://photos.prnewswire.com/prnh/20120215/MM54604LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/harwood-feffer-llp-announces-investigation-of-hansen-medical-inc-300255742.html
SOURCE Harwood Feffer LLP
